Ocugen Inc
Ownership
Ownership Structure
Who owns Ocugen Inc (OCGN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.4% of the shares are freely tradable; institutional investors hold 44.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Millennium Management LLC | 4.11 | 13,943,252 | +1.6 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.07 | 13,804,111 | +0.0 | 03/31/2026 |
| State Street Corp | 2.85 | 9,670,191 | +143.0 | 03/31/2026 |
| Marshall Wace Asset Management Ltd | 2.37 | 8,052,350 | +218.2 | 03/31/2026 |
| BlackRock Inc | 2.15 | 7,304,979 | +60.3 | 03/31/2026 |
| UBS Group AG | 2.15 | 7,280,320 | +50.1 | 03/31/2026 |
| RTW INVESTMENTS, LLC | 1.97 | 6,666,666 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 4.35 | 14,760,214 | -1.1 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.00 | 10,177,094 | +0.0 | 08/31/2026 |
| iShares Russell 2000 ETF | 2.53 | 8,588,990 | -0.6 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Musunuri Shankar | Chief Executive Officer | 5,575,232 | 5,575,232 $ | Sep 9, 2026 | both |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | Musunuri Shankar | Chief Executive Officer | Sell | 57,264 | 1.12 | 64,136 |
| Sep 9, 2026 | Musunuri Shankar | Chief Executive Officer | Sell | 468,727 | 1.12 | 524,974 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.